Cargando…

Management of chronic renal allograft dysfunction and when to re-transplant

Despite the advances in renal transplantation over the last decades, chronic allograft dysfunction remains the largest concern for patients, their families, clinicians and other members of the multi-disciplinary team. Although we have made progress in improving patient and renal allograft survival w...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Richard J., Marks, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394652/
https://www.ncbi.nlm.nih.gov/pubmed/30039433
http://dx.doi.org/10.1007/s00467-018-4000-9
_version_ 1783398939962114048
author Baker, Richard J.
Marks, Stephen D.
author_facet Baker, Richard J.
Marks, Stephen D.
author_sort Baker, Richard J.
collection PubMed
description Despite the advances in renal transplantation over the last decades, chronic allograft dysfunction remains the largest concern for patients, their families, clinicians and other members of the multi-disciplinary team. Although we have made progress in improving patient and renal allograft survival within the first year after transplantation, the rate of transplant failure with requirement for commencement of dialysis or re-transplantation has essentially remained unchanged. It is important that paediatric and adult nephrologists and transplant surgeons, not only manage their patients and their renal transplants but provide the best chronic kidney disease management during the time of decline of renal allograft function. The gold standard for patients with Stage V chronic kidney disease is to have pre-emptive living donor transplants, where possible and the same is true for healthy renal transplant recipients with declining renal allograft function. The consideration for children and young people as they embark on their end-stage kidney disease journey is the risk-benefit profile of giving the best immunologically matched and good quality renal allografts as they may require multiple renal transplantation operations during their lifetime.
format Online
Article
Text
id pubmed-6394652
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63946522019-03-15 Management of chronic renal allograft dysfunction and when to re-transplant Baker, Richard J. Marks, Stephen D. Pediatr Nephrol Educational Review Despite the advances in renal transplantation over the last decades, chronic allograft dysfunction remains the largest concern for patients, their families, clinicians and other members of the multi-disciplinary team. Although we have made progress in improving patient and renal allograft survival within the first year after transplantation, the rate of transplant failure with requirement for commencement of dialysis or re-transplantation has essentially remained unchanged. It is important that paediatric and adult nephrologists and transplant surgeons, not only manage their patients and their renal transplants but provide the best chronic kidney disease management during the time of decline of renal allograft function. The gold standard for patients with Stage V chronic kidney disease is to have pre-emptive living donor transplants, where possible and the same is true for healthy renal transplant recipients with declining renal allograft function. The consideration for children and young people as they embark on their end-stage kidney disease journey is the risk-benefit profile of giving the best immunologically matched and good quality renal allografts as they may require multiple renal transplantation operations during their lifetime. Springer Berlin Heidelberg 2018-07-23 2019 /pmc/articles/PMC6394652/ /pubmed/30039433 http://dx.doi.org/10.1007/s00467-018-4000-9 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Educational Review
Baker, Richard J.
Marks, Stephen D.
Management of chronic renal allograft dysfunction and when to re-transplant
title Management of chronic renal allograft dysfunction and when to re-transplant
title_full Management of chronic renal allograft dysfunction and when to re-transplant
title_fullStr Management of chronic renal allograft dysfunction and when to re-transplant
title_full_unstemmed Management of chronic renal allograft dysfunction and when to re-transplant
title_short Management of chronic renal allograft dysfunction and when to re-transplant
title_sort management of chronic renal allograft dysfunction and when to re-transplant
topic Educational Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394652/
https://www.ncbi.nlm.nih.gov/pubmed/30039433
http://dx.doi.org/10.1007/s00467-018-4000-9
work_keys_str_mv AT bakerrichardj managementofchronicrenalallograftdysfunctionandwhentoretransplant
AT marksstephend managementofchronicrenalallograftdysfunctionandwhentoretransplant